Physician profile
John Moscona
NPI 1710202916
$31,554.91
in general payments reported to CMS, 2019-2025
23 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $1,641 · 2021: $2,007 · 2022: $2,274 · 2023: $1,189 · 2024: $6,395 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $3,052 · Travel and Lodging: $2,970 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,160.00 |
| Food and Beverage | $3,052.00 |
| Travel and Lodging | $2,969.53 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20,443.42 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $5,486.72 | 2021-2025 | Navitor, Mitraclip, Amplatzer Amulet |
| Boston Scientific Corporation | $3,103.80 | 2020-2023 | |
| Edwards Lifesciences Corporation | $580.21 | 2020-2025 | Sapien 3 Ultra Resilia, Evoque |
| Cardiovascular Systems INC. | $463.42 | 2019-2021 | |
| Shockwave Medical, INC | $257.90 | 2021-2022 | |
| Asahi Intecc USA, INC. | $234.34 | 2020 | |
| Celonova Biosciences, INC. | $227.15 | 2020 | |
| Medtronic Vascular, INC. | $184.39 | 2019-2020 | |
| Abiomed | $89.78 | 2022-2024 | Impella |
| Inari Medical, INC. | $82.98 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Acist Medical Systems, INC. | $65.88 | 2022-2024 | |
| Impulse Dynamics (USA) INC. | $55.29 | 2023 | Optimizer |
| Pfizer INC. | $53.22 | 2024-2025 | |
| Terumo Medical Corporation | $44.44 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $43.69 | 2024-2025 | Ozempic |
| Janssen Pharmaceuticals, INC | $25.86 | 2019 | |
| Philips North America LLC | $23.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.99 | 2025 | Lifevest |
| Penumbra, INC. | $20.10 | 2025 | Indigo System |
| Endovascular Engineering INC. | $17.15 | 2025 | Helo Thrombectomy System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.86 | 2021 | |
| Siemens Medical Solutions USA, INC. | $13.57 | 2023 | Naeotom Alpha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moscona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.